angela . 8/10/26 angela . 8/10/26

Standard Bioconjugation Chemistry Comes with Hidden Traps for Targeted LNPs

Read More

angela . 7/31/26 angela . 7/31/26

Tools for Targeted-LNPs: Plug-and-Play Simplicity vs in vivo Potency

Read More

Joe Yu 7/22/26 Joe Yu 7/22/26

CD7-targeting tLNPs for T-cell and NK delivery.  

Read More

Joe Yu 7/15/26 Joe Yu 7/15/26

A few key updates from our recent in vivo studies

Read More

Joe Yu 7/10/26 Joe Yu 7/10/26

The Power of Precision CD8+ tLNPs

CD8 Targeted Lipid Nanoparticle Validation

Read More

Joe Yu 11/28/25 Joe Yu 11/28/25

The In Vivo CAR-T Race Heats Up

Read More

Joe Yu 11/21/25 Joe Yu 11/21/25

CD8-eGFP-LNP shows high percentage of conjugated LNP,  and high degree of CD8-cell- specific transfection

Read More

Joe Yu 11/14/25 Joe Yu 11/14/25

Tiva Biosciences is pleased to launch off-the-shelf products to accelerate targeted-LNP development

Read More

Joe Yu 11/7/25 Joe Yu 11/7/25

Tiva Biosciences is proud to introduce Ready-to-Target binder-lipid product

Read More

Joe Yu 10/17/25 Joe Yu 10/17/25

A stability boost for in vivo Cell and Gene Therapy

Read More

Joe Yu 10/10/25 Joe Yu 10/10/25

tLNP engineering modularized – cutting weeks off the tLNP workflow

Read More